Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting-Reference-Cited by-同舟云学术

Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

Published:2008-11 Issue:11 Volume:8 Page:1733-1742
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Navari Rudolph M¹

Affiliation:

1. Professor of Medicine, Assistant Dean and Director Indiana University School of Medicine South Bend Director, Walther Cancer Research Center University of Notre Dame,1234 Notre Dame Avenue, South Bend, IN 46617, USA.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1586/14737140.8.11.1733

Reference48 articles.

1. Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings

2. Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

3. Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin

4. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

2. USFDA-approved parenteral peptide formulations and excipients: Industrial perspective;Journal of Drug Delivery Science and Technology;2024-05

3. Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature;La radiologia medica;2024-02-14

4. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant;International Journal of Molecular Sciences;2023-11-03

5. Fosaprepitant for postoperative nausea and vomiting in patients undergoing laparoscopic gastrointestinal surgery: a randomised trial;British Journal of Anaesthesia;2023-10